{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:32:00Z","timestamp":1785540720333,"version":"3.56.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Foundation of Shandong Province","award":["ZR2022MB134"],"award-info":[{"award-number":["ZR2022MB134"]}]},{"name":"the project of Weifang University of Science and Technology","award":["2024XJKJ06"],"award-info":[{"award-number":["2024XJKJ06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-00851-0","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T11:06:26Z","timestamp":1740999986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Computational study on the mechanism of small molecules inhibiting NLRP3 with ensemble docking and molecular dynamic simulations"],"prefix":"10.1186","volume":"26","author":[{"given":"Pingyang","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizheng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"851_CR1","first-page":"1393","volume":"19","author":"X Li","year":"2020","unstructured":"Li X, Shang X, Sun L. Tacrolimus reduces atherosclerotic plaque formation in ApoE(-\/-) mice by inhibiting NLRP3 inflammatory corpuscles. Experimental Therapeutic Med. 2020;19:1393\u20139.","journal-title":"Experimental Therapeutic Med"},{"key":"851_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/978-981-13-8871-2_19","volume":"1165","author":"L Li","year":"2019","unstructured":"Li L, Tang W, Yi F. Role of Inflammasome in chronic kidney disease. Adv Exp Med Biol. 2019;1165:407\u201321.","journal-title":"Adv Exp Med Biol"},{"key":"851_CR3","doi-asserted-by":"publisher","first-page":"e1007795","DOI":"10.1371\/journal.ppat.1007795","volume":"15","author":"L Lin","year":"2019","unstructured":"Lin L, Xu L, Lv W, Han L, Xiang Y, Fu L, Jin M, Zhou R, Chen H, Zhang A. An NLRP3 inflammasome-triggered cytokine storm contributes to streptococcal toxic shock-like syndrome (STSLS). PLoS Pathog. 2019;15:e1007795.","journal-title":"PLoS Pathog"},{"key":"851_CR4","doi-asserted-by":"crossref","unstructured":"Li Z, Chen Y, Jiang X, Lu P, Wang C, Li Z, Yu X, Yang Z, Ma S, Du S, et al. Novel sulfonylurea-based NLRP3 inflammasome inhibitor for efficient treatment of nonalcoholic steatohepatitis, endotoxic shock, and colitis. J Med Chem 2023.","DOI":"10.1021\/acs.jmedchem.3c00894"},{"key":"851_CR5","doi-asserted-by":"publisher","first-page":"115784","DOI":"10.1016\/j.ejmech.2023.115784","volume":"260","author":"C Shi","year":"2023","unstructured":"Shi C, Zhang X, Chi X, Zhou YR, Lyu W, Gao T, Zhou J, Chen Y, Yi C, Sun X, et al. Discovery of NLRP3 inhibitors using machine learning: identification of a hit compound to treat NLRP3 activation-driven diseases. Eur J Med Chem. 2023;260:115784.","journal-title":"Eur J Med Chem"},{"key":"851_CR6","doi-asserted-by":"publisher","first-page":"115393","DOI":"10.1016\/j.biopha.2023.115393","volume":"166","author":"X Zheng","year":"2023","unstructured":"Zheng X, Zhao D, Jin Y, Liu Y, Liu D. Role of the NLRP3 inflammasome in gynecological disease. Biomed Pharmacother. 2023;166:115393.","journal-title":"Biomed Pharmacother"},{"key":"851_CR7","doi-asserted-by":"publisher","first-page":"110808","DOI":"10.1016\/j.intimp.2023.110808","volume":"123","author":"L Yang","year":"2023","unstructured":"Yang L, Huang Y, Chen F, Wang Y, Su K, Zhao M, Tao W, Liu W. Berberine attenuates depression-like behavior by modulating the hippocampal NLRP3 ubiquitination signaling pathway through Trim65. Int Immunopharmacol. 2023;123:110808.","journal-title":"Int Immunopharmacol"},{"key":"851_CR8","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","volume":"15","author":"RC Coll","year":"2019","unstructured":"Coll RC, Hill JR, Day CJ, Zamoshnikova A, Boucher D, Massey NL, Chitty JL, Fraser JA, Jennings MP, Robertson AAB, Schroder K. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat Chem Biol. 2019;15:556\u20139.","journal-title":"Nat Chem Biol"},{"key":"851_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll RC, Robertson AA, Chae JJ, Higgins SC, Mu\u00f1oz-Planillo R, Inserra MC, Vetter I, Dungan LS, Monks BG, Stutz A, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015;21:248\u201355.","journal-title":"Nat Med"},{"key":"851_CR10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41589-019-0278-6","volume":"15","author":"A Tapia-Abell\u00e1n","year":"2019","unstructured":"Tapia-Abell\u00e1n A, Angosto-Bazarra D, Mart\u00ednez-Banaclocha H, de Torre-Minguela C, Cer\u00f3n-Carrasco JP, P\u00e9rez-S\u00e1nchez H, Arostegui JI, Pelegrin P. MCC950 closes the active conformation of NLRP3 to an inactive state. Nat Chem Biol. 2019;15:560\u20134.","journal-title":"Nat Chem Biol"},{"key":"851_CR11","doi-asserted-by":"publisher","first-page":"167309","DOI":"10.1016\/j.jmb.2021.167309","volume":"433","author":"C Dekker","year":"2021","unstructured":"Dekker C, Mattes H, Wright M, Boettcher A, Hinniger A, Hughes N, Kapps-Fouthier S, Eder J, Erbel P, Stiefl N, et al. Crystal structure of NLRP3 NACHT Domain with an inhibitor defines mechanism of Inflammasome Inhibition. J Mol Biol. 2021;433:167309.","journal-title":"J Mol Biol"},{"key":"851_CR12","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1021\/acs.jmedchem.0c01924","volume":"64","author":"Z Dai","year":"2021","unstructured":"Dai Z, Chen XY, An LY, Li CC, Zhao N, Yang F, You ST, Hou CZ, Li K, Jiang C, et al. Development of Novel Tetrahydroquinoline inhibitors of NLRP3 inflammasome for potential treatment of DSS-Induced mouse colitis. J Med Chem. 2021;64:871\u201389.","journal-title":"J Med Chem"},{"key":"851_CR13","doi-asserted-by":"crossref","unstructured":"Jiang Y, He L, Green JC, Blevins H, Zhang S. Discovery of second-generation NLRP3 inflammasome inhibitors: Design, synthesis, and biological characterization. J Med Chem. 2019:2019.","DOI":"10.1021\/acs.jmedchem.9b01155"},{"key":"851_CR14","doi-asserted-by":"publisher","first-page":"107367","DOI":"10.1016\/j.cmpb.2023.107367","volume":"231","author":"R Singh","year":"2023","unstructured":"Singh R, Purohit R. Computational analysis of protein-ligand interaction by targeting a cell cycle restrainer. Comput Methods Programs Biomed. 2023;231:107367.","journal-title":"Comput Methods Programs Biomed"},{"key":"851_CR15","first-page":"2711","volume":"34","author":"N Kalsi","year":"2016","unstructured":"Kalsi N, Gopalakrishnan C, Rajendran V, Purohit R. Biophysical aspect of phosphatidylinositol 3-kinase and role of oncogenic mutants (E542K & E545K). J Biomol Struct Dyn. 2016;34:2711\u201321.","journal-title":"J Biomol Struct Dyn"},{"key":"851_CR16","doi-asserted-by":"publisher","first-page":"120729","DOI":"10.1016\/j.carbpol.2023.120729","volume":"310","author":"VK Bhardwaj","year":"2023","unstructured":"Bhardwaj VK, Purohit R. A comparative study on inclusion complex formation between formononetin and \u03b2-cyclodextrin derivatives through multiscale classical and umbrella sampling simulations. Carbohydr Polym. 2023;310:120729.","journal-title":"Carbohydr Polym"},{"key":"851_CR17","doi-asserted-by":"publisher","first-page":"110094","DOI":"10.1016\/j.jtbi.2019.110094","volume":"486","author":"V Bhardwaj","year":"2020","unstructured":"Bhardwaj V, Singh R, Singh P, Purohit R, Kumar S. Elimination of bitter-off taste of stevioside through structure modification and computational interventions. J Theor Biol. 2020;486:110094.","journal-title":"J Theor Biol"},{"key":"851_CR18","doi-asserted-by":"publisher","first-page":"7693","DOI":"10.1080\/07391102.2021.1900918","volume":"40","author":"R Singh","year":"2022","unstructured":"Singh R, Bhardwaj VK, Sharma J, Das P, Purohit R. Identification of selective cyclin-dependent kinase 2 inhibitor from the library of pyrrolone-fused benzosuberene compounds: an in silico exploration. J Biomol Struct Dyn. 2022;40:7693\u2013701.","journal-title":"J Biomol Struct Dyn"},{"key":"851_CR19","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/cbf.3753","volume":"40","author":"R Singh","year":"2022","unstructured":"Singh R, Bhardwaj VK, Purohit R. Inhibition of nonstructural protein 15 of SARS-CoV-2 by golden spice: a computational insight. Cell Biochem Funct. 2022;40:926\u201334.","journal-title":"Cell Biochem Funct"},{"key":"851_CR20","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.1021\/acs.jcim.3c00477","volume":"63","author":"S Deng","year":"2023","unstructured":"Deng S, Zhang H, Gou R, Luo D, Liu Z, Zhu F, Xue W. Structure-based Discovery of a Novel Allosteric inhibitor against human dopamine transporter. J Chem Inf Model. 2023;63:4458\u201367.","journal-title":"J Chem Inf Model"},{"key":"851_CR21","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1021\/acschemneuro.1c00127","volume":"12","author":"G Tu","year":"2021","unstructured":"Tu G, Fu T, Yang F, Yang J, Zhang Z, Yao X, Xue W, Zhu F. Understanding the Polypharmacological profiles of Triple Reuptake inhibitors by Molecular Simulation. ACS Chem Neurosci. 2021;12:2013\u201326.","journal-title":"ACS Chem Neurosci"},{"key":"851_CR22","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1021\/acschemneuro.3c00155","volume":"14","author":"G Tu","year":"2023","unstructured":"Tu G, Xu B, Luo D, Liu J, Liu Z, Chen G, Xue W. Multi-state model-based identification of cryptic Allosteric sites on Human Serotonin Transporter. ACS Chem Neurosci. 2023;14:1686\u201394.","journal-title":"ACS Chem Neurosci"},{"key":"851_CR23","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1021\/acschemneuro.1c00694","volume":"13","author":"W Xue","year":"2022","unstructured":"Xue W, Fu T, Deng S, Yang F, Yang J, Zhu F. Molecular mechanism for the Allosteric inhibition of the human serotonin transporter by Antidepressant Escitalopram. ACS Chem Neurosci. 2022;13:340\u201351.","journal-title":"ACS Chem Neurosci"},{"key":"851_CR24","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.2174\/0929867328666210708090123","volume":"29","author":"F Yang","year":"2022","unstructured":"Yang F, Yang J, Zhang Z, Tu G, Yao X, Xue W, Zhu F. Recent advances in computer-aided antiviral Drug Design Targeting HIV-1 Integrase and Reverse Transcriptase Associated Ribonuclease H. Curr Med Chem. 2022;29:1664\u201376.","journal-title":"Curr Med Chem"},{"key":"851_CR25","doi-asserted-by":"publisher","first-page":"18139","DOI":"10.1021\/ja9064359","volume":"131","author":"CR Guimar\u00e3es","year":"2009","unstructured":"Guimar\u00e3es CR, Kopecky DJ, Mihalic J, Shen S, Jeffries S, Thibault ST, Chen X, Walker N, Cardozo M. Thermodynamic analysis of mRNA cap binding by the human initiation factor eIF4E via free energy perturbations. J Am Chem Soc. 2009;131:18139\u201346.","journal-title":"J Am Chem Soc"},{"key":"851_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1021\/ct400783h","volume":"10","author":"G Gerogiokas","year":"2014","unstructured":"Gerogiokas G, Calabro G, Henchman RH, Southey MW, Law RJ, Michel J. Prediction of small Molecule Hydration Thermodynamics with Grid Cell Theory. J Chem Theory Comput. 2014;10:35\u201348.","journal-title":"J Chem Theory Comput"},{"key":"851_CR27","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.1021\/acs.jcim.0c00934","volume":"60","author":"D Hao","year":"2020","unstructured":"Hao D, He X, Ji B, Zhang S, Wang J. How well does the Extended Linear Interaction Energy Method Perform in accurate binding Free Energy calculations? J Chem Inf Model. 2020;60:6624\u201333.","journal-title":"J Chem Inf Model"},{"key":"851_CR28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/cbdd.13977","volume":"99","author":"P Li","year":"2022","unstructured":"Li P, Niu Y, Li S, Zu X, Xiao M, Yin L, Feng J, He J, Shen Y. Identification of an AXL kinase inhibitor in triple-negative breast cancer by structure-based virtual screening and bioactivity test. Chem Biol Drug Des. 2022;99:222\u201332.","journal-title":"Chem Biol Drug Des"},{"key":"851_CR29","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.drudis.2022.01.012","volume":"27","author":"Y Niu","year":"2022","unstructured":"Niu Y, Ji H. Current developments in extracellular-regulated protein kinase (ERK1\/2) inhibitors. Drug Discov Today. 2022;27:1464\u201373.","journal-title":"Drug Discov Today"},{"key":"851_CR30","doi-asserted-by":"publisher","first-page":"12441","DOI":"10.1039\/C9RA01657K","volume":"9","author":"Y Niu","year":"2019","unstructured":"Niu Y, Yao X, Ji H. Importance of protein flexibility in ranking ERK2 type I(1\/2) inhibitor affinities: a computational study. RSC Adv. 2019;9:12441\u201354.","journal-title":"RSC Adv"},{"key":"851_CR31","doi-asserted-by":"publisher","first-page":"5622","DOI":"10.1039\/C5CP06257H","volume":"18","author":"Y Niu","year":"2016","unstructured":"Niu Y, Li S, Pan D, Liu H, Yao X. Computational study on the unbinding pathways of B-RAF inhibitors and its implication for the difference of residence time: insight from random acceleration and steered molecular dynamics simulations. Phys Chem Chem Phys. 2016;18:5622\u20139.","journal-title":"Phys Chem Chem Phys"},{"key":"851_CR32","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1021\/acs.jcim.2c01530","volume":"63","author":"DJ Hsu","year":"2023","unstructured":"Hsu DJ, Davidson RB, Sedova A, Glaser J. tinyIFD: a high-throughput binding pose refinement Workflow through Induced-Fit ligand docking. J Chem Inf Model. 2023;63:3438\u201347.","journal-title":"J Chem Inf Model"},{"key":"851_CR33","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/jcc.540161106","volume":"16","author":"P Cieplak","year":"1995","unstructured":"Cieplak P, Cornell WD, Bayly C, Kollman PA. Application of the multimolecule and multiconformational RESP methodology to biopolymers: charge derivation for DNA, RNA, and proteins. J Comput Chem. 1995;16:1357\u201377.","journal-title":"J Comput Chem"},{"key":"851_CR34","doi-asserted-by":"publisher","first-page":"10269","DOI":"10.1021\/j100142a004","volume":"97","author":"CI Bayly","year":"1993","unstructured":"Bayly CI, Cieplak P, Cornell W, Kollman PA. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model. J Phys Chem. 1993;97:10269\u201380.","journal-title":"J Phys Chem"},{"key":"851_CR35","doi-asserted-by":"publisher","first-page":"8070","DOI":"10.1021\/jp9717655","volume":"102","author":"T Fox","year":"1998","unstructured":"Fox T, Kollman PA. Application of the RESP Methodology in the parametrization of Organic solvents. J Phys Chem. 1998;102:8070\u20139.","journal-title":"J Phys Chem"},{"key":"851_CR36","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","volume":"16","author":"C Tian","year":"2020","unstructured":"Tian C, Kasavajhala K, Belfon KAA, Raguette L, Huang H, Migues AN, Bickel J, Wang Y, Pincay J, Wu Q, Simmerling C. ff19SB: amino-acid-specific protein backbone parameters trained against Quantum Mechanics Energy Surfaces in Solution. J Chem Theory Comput. 2020;16:528\u201352.","journal-title":"J Chem Theory Comput"},{"key":"851_CR37","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79:926\u201335.","journal-title":"J Chem Phys"},{"key":"851_CR38","doi-asserted-by":"publisher","first-page":"054112","DOI":"10.1063\/5.0040966","volume":"154","author":"AC Simmonett","year":"2021","unstructured":"Simmonett AC, Brooks BR. A compression strategy for particle mesh Ewald theory. J Chem Phys. 2021;154:054112.","journal-title":"J Chem Phys"},{"key":"851_CR39","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","volume":"23","author":"J-P Ryckaert","year":"1977","unstructured":"Ryckaert J-P, Ciccotti G, Berendsen HJC. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys. 1977;23:327\u201341.","journal-title":"J Comput Phys"},{"key":"851_CR40","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/ar000033j","volume":"33","author":"PA Kollman","year":"2000","unstructured":"Kollman PA, Massova I, Reyes C, Kuhn B, Huo SH, Chong L, Lee M, Lee T, Duan Y, Wang W, et al. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res. 2000;33:889\u201397.","journal-title":"Acc Chem Res"},{"key":"851_CR41","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1021\/jm060522a","volume":"49","author":"PD Lyne","year":"2006","unstructured":"Lyne PD, Lamb ML, Saeh JC. Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. J Med Chem. 2006;49:4805\u20138.","journal-title":"J Med Chem"},{"key":"851_CR42","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1021\/acs.jcim.1c00355","volume":"61","author":"J Yang","year":"2021","unstructured":"Yang J, Lin X, Xing N, Zhang Z, Zhang H, Wu H, Xue W. Structure-based Discovery of Novel Nonpeptide inhibitors targeting SARS-CoV-2\u00a0M(pro). J Chem Inf Model. 2021;61:3917\u201326.","journal-title":"J Chem Inf Model"},{"key":"851_CR43","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1039\/C5CP05771J","volume":"18","author":"W Xue","year":"2016","unstructured":"Xue W, Wang P, Li B, Li Y, Xu X, Yang F, Yao X, Chen YZ, Xu F, Zhu F. Identification of the inhibitory mechanism of FDA approved selective serotonin reuptake inhibitors: an insight from molecular dynamics simulation study. Phys Chem Chem Phys. 2016;18:3260\u201371.","journal-title":"Phys Chem Chem Phys"},{"key":"851_CR44","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1002\/prot.24922","volume":"83","author":"TV Lee","year":"2015","unstructured":"Lee TV, Johnson RD, Arcus VL, Lott JS. Prediction of the substrate for nonribosomal peptide synthetase (NRPS) adenylation domains by virtual screening. Proteins-Structure Function Bioinf. 2015;83:2052\u201366.","journal-title":"Proteins-Structure Function Bioinf"},{"key":"851_CR45","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1021\/acs.jcim.5b00056","volume":"55","author":"N Li","year":"2015","unstructured":"Li N, Ainsworth RI, Ding B, Hou T, Wang W. Using hierarchical virtual screening to combat Drug Resistance of the HIV-1 protease. J Chem Inf Model. 2015;55:1400\u201312.","journal-title":"J Chem Inf Model"},{"key":"851_CR46","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov. 2015;10:449\u201361.","journal-title":"Expert Opin Drug Discov"},{"key":"851_CR47","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/j.bbagen.2012.06.001","volume":"1820","author":"D Pan","year":"2012","unstructured":"Pan D, Xue W, Zhang W, Liu H, Yao X. Understanding the drug resistance mechanism of hepatitis C virus NS3\/4A to ITMN-191 due to R155K, A156V, D168A\/E mutations: a computational study. Biochim Et Biophys Acta-General Subj. 2012;1820:1526\u201334.","journal-title":"Biochim Et Biophys Acta-General Subj"},{"key":"851_CR48","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.chemolab.2016.03.015","volume":"154","author":"D Pan","year":"2016","unstructured":"Pan D, Niu Y, Xue W, Bai Q, Liu H, Yao X. Computational study on the drug resistance mechanism of hepatitis C virus NS5B RNA-dependent RNA polymerase mutants to BMS-791325 by molecular dynamics simulation and binding free energy calculations. Chemometr Intell Lab Syst. 2016;154:185\u201393.","journal-title":"Chemometr Intell Lab Syst"},{"key":"851_CR49","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A","volume":"20","author":"JR Weiser","year":"1999","unstructured":"Weiser JR, Shenkin PS, Still WC. Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO). J Comput Chem. 1999;20:217\u201330.","journal-title":"J Comput Chem"},{"key":"851_CR50","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0022-2836(85)90230-X","volume":"181","author":"M Levitt","year":"1985","unstructured":"Levitt M, Sander C, Stern PS. Protein normal-mode dynamics - Trypsin-Inhibitor, Crambin, Ribonuclease and lysozyme. J Mol Biol. 1985;181:423\u201347.","journal-title":"J Mol Biol"},{"key":"851_CR51","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/j.apsb.2021.01.018","volume":"11","author":"Q Dai","year":"2021","unstructured":"Dai Q, Yan Y, Ning X, Li G, Yu J, Deng J, Yang L, Li GB. AncPhore: a versatile tool for anchor pharmacophore steered drug discovery with applications in discovery of new inhibitors targeting metallo-\u03b2-lactamases and indoleamine\/tryptophan 2,3-dioxygenases. Acta Pharm Sinica B. 2021;11:1931\u201346.","journal-title":"Acta Pharm Sinica B"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00851-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-00851-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00851-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T11:45:18Z","timestamp":1741002318000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-025-00851-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["851"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-00851-0","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Pingyang Qin, Yuzhen Niu, Jizheng Duan and Ping Lin, hereby grant our explicit consent for the publication in BMC Pharmacology and Toxicology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}